Earningsreport

Q2/2023 6/30/2023 EPS -0.810 ZacksConsensus -0.850 ActVsEst 0.040 - Beat

AN2 Therapeutics, Inc.  (ANTX) 
US:NYSE Investor Relations: ir.antheminc.com